Pharvaris N.V. (PHVS) stock

PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026Score 4/30

$33.83−0.35 (-1.02%)

Close on Nov 12, 2026Market cap $2.21BP/E –Yield –

Pharvaris ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Pharvaris has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?